Peptidetesting

All labs

Veeda Lifesciences (Analytical Sciences)

Public information only

A division of a long-established contract research firm based in Ahmedabad, this entity offers peptide and biologics analysis. It has verified legal registration, but its accreditations remain publicly unconfirmed.

Listed - from four separately substantiated review fields. See them

Legal entity
VEEDA CLINICAL RESEARCH LIMITED
Registration
U73100GJ2004PLC044023 · 2004-04-23 (Registrar of Companies, ROC Ahmedabad (India))
Location
Ahmedabad, India Asia · Shivalik Plaza-A, 2nd Floor, Opp. Ahmedabad Management Association, Ambawadi, Ahmedabad - 380015, Gujarat, India
Website
veedalifesciences.com
Indicative price
On request

Four separate review fields

Existing overall assessment: Listed

The overall assessment is not an average of these four fields. Each field answers a different question and cannot offset another.

Substantiated

Who is behind the laboratory?

A responsible legal entity and its leadership or operator are publicly substantiated.

Boundary: Identity and responsibility do not establish analytical competence.

View 4 signals and their evidence
Signal profile - Counts show composition, not a score. Core evidence 2 Supporting evidence 1 Boundary 1 Contradiction 0
  • Positive CIN U73100GJ2004PLC044023 confirmed across company website, Tracxn profile, and BSE India DRHP document. 'Veeda Lifesciences (Analytical Sciences)' is a brand/division, not a separate legal entity.
  • Positive At least one named key person is independently attributed to this laboratory: Binoy Gardi (+3 weitere).
  • Positive The registered address Shivalik Plaza-A, 2nd Floor, Opp. Ahmedabad Management Association, Ambawadi, Ahmedabad - 380015, Gujarat, India is confirmed by Registrar of Companies, ROC Ahmedabad (India).
  • Neutral Veeda Lifesciences' own presentation states it is "an independent, institutional investors owned, board governed and professionally managed contract research group," but no third-party source in the evidence independently confirms this independence. A joint "Center of Excellence" with Agilent is described, which is a vendor partnership rather than evidence of separate ownership.
Partially substantiated

Is the procedure technically substantiated for peptides?

Specific method or process evidence exists, but the full method-by-matrix contract is not public.

Boundary: Lack of accreditation is normal here and is not a negative signal.

View 5 signals and their evidence
Signal profile - Counts show composition, not a score. Core evidence 0 Supporting evidence 2 Boundary 3 Contradiction 0
  • Positive The laboratory names concrete instrumentation: Agilent platforms (Joint Analytical Center of Excellence).
  • Positive Veeda Lifesciences is part of the Veeda Clinical Research Group, an established CRO with a pharma/biopharma background. DSIR-recognized R&D laboratory, CDSCO-certified, USFDA-audited. This represents a competency CONTEXT that is to be evaluated separately from the ISO 17025 scope.
  • Neutral No verifiable accreditation. For a laboratory that accepts private samples this is the norm, not a mark against it.
  • Neutral ISO/IEC 17025 is claimed, but no entry in the accreditation body's own register could be cited; the claim can neither be verified nor refuted.
  • Neutral Domain age ~781 days; no claimed years on the website. The Analytical Sciences/Biopharma division is relatively young, although Veeda Clinical Research has existed as a CRO for longer.
Not assessed

Can a report be traced back through the issuer?

The available verification step does not support a reliable conclusion.

Boundary: Report confirmation establishes neither analytical competence nor the contents of an individual vial.

No public signals in this review field.

Not publicly established

Has actual measurement performance been checked externally?

No suitable independent evidence of actual measurement performance was publicly established.

Boundary: Testimonials, report volume and average purity values are not external performance evidence.

No public signals in this review field.

Our honest take

What Do We Know About Veeda Lifesciences (Analytical Sciences)?

Reports from Veeda Lifesciences (Analytical Sciences) can be considered as coming from a real, legally verified laboratory, but public evidence does not yet converge strongly enough to independently confirm analytical competence for peptide testing.

The strongest positive signals are concrete: the parent entity, Veeda Clinical Research Limited, is registered with the Registrar of Companies in Ahmedabad under CIN U73100GJ2004PLC044023, originally incorporated on April 23, 2004, giving over 20 years of registration history. A physical registered address at Shivalik Plaza-A, Ambawadi, Ahmedabad is confirmed by ROC records. Named leadership is independently attributed, including founder and Managing Director Binoy Gardi plus three additional directors. The laboratory discloses concrete Agilent instrumentation through a Joint Analytical Center of Excellence and explicitly lists peptide development and peptide characterization among its service offerings.

The reason public evidence does not converge to the higher 'Substantiated' rating is that every accreditation the laboratory claims - ISO/IEC 17025, GLP, CDSCO certification, DSIR recognition, USFDA audited, AAALAC, and OLAW - remains unverified because no entry in any accreditation body's own register was cited. This is a neutral limit of public evidence, not a finding of fault; for a laboratory oriented toward business customers, missing verifiable accreditation scope is the normal case rather than a red flag.

No independent reputation footprint was found across 18 supplied sources: zero mentions in forum discussions, scientific publications, customer complaints, or enforcement records. The Analytical Sciences division's domain was registered on May 22, 2024, making it relatively young, though the parent CRO predates it by two decades. No concrete open concern such as fabrication, borrowed legitimacy, or enforcement action was identified. These are signals, not a verdict.

Below: the material this assessment is built on.

People behind the lab

Binoy Gardi
Founder, Group CEO, Managing Director
Nitin Deshmukh
Independent Director and Chairman
Rakesh Bhartia
Independent Director
David Kenny
Independent Director

Accreditation

ISO/IEC 17025: Claimed, unverified ISO 17025 accreditation confirmed only for pre-clinical facilities at Devarahosahally per DRHP [14]. The Analytical Sciences/Biopharma division at Peenya (Bengaluru) has no ISO 17025 documented. No NABL register entry found for the analytical division.

GLP: Claimed, unverified GLP certification claimed for pre-clinical facilities [1][14]; GLP-compliant bioanalytical services mentioned [13]. GLP is a quality system for non-clinical safety studies, distinct from ISO/IEC 17025 competence standard. No certificate number or register entry provided.

CDSCO certification: Claimed, unverified CDSCO certification announced for Peenya biopharma site [15]. No certificate number or register entry provided. Does not constitute ISO/IEC 17025 accreditation.

DSIR recognition: Claimed, unverified DSIR R&D laboratory recognition cited for biopharma division [9][10]. Not an accreditation for testing competence.

USFDA audited: Claimed, unverified Listed under 'Accreditations & Certifications' in corporate presentation [1]. No audit details, date, or findings provided.

AAALAC: Claimed, unverified AAALAC accreditation confirmed for pre-clinical facilities (Bioneeds/Devarahosahally) [8][14]. Not applicable to analytical sciences.

OLAW: Claimed, unverified OLAW accreditation mentioned in DRHP for pre-clinical facilities [14]. Not applicable to analytical sciences.

What is tested - and with what

Methods & capabilities Structural analytical characterization of complex biologics (peptides, mAbs, ADCs, therapeutic proteins) · analytical_characterizationGLP-compliant bioanalytical services · bioanalytical

Context without a quality rating

These signals describe access, the public trail and documents. They do not colour any of the four review fields.

Audit complete

Access and offering · 3
  • Positive The bioanalytical services page explicitly lists 'Peptid-Entwicklung' (peptide development) and the brochures page mentions 'Peptide, Oligonukleotide, Insulin und Analoga, Fusionsproteine und rekombinante Proteine, mAbs, ADCs' under integrated biosimilar development solutions.
  • Neutral The laboratory's public ordering route addresses business customers only; no private ordering route was found.
  • Neutral No prices are mentioned; contact required.
Public and digital trail · 3
  • Positive Originally incorporated on April 23, 2004 as 'Clinsearch Labs Private Limited', later rebranded. Over 20 years of registration history.
  • Neutral A review of all 18 supplied sources yields zero mentions of "Veeda Lifesciences," "Veeda Analytical Sciences," or any variant spelling in forum discussions, scientific publications, customer complaints, or enforcement records. Neither a positive nor a negative reputation claim for Veeda Lifesciences can be substantiated from the provided material.
  • Neutral The domain for Veeda Lifesciences (Analytical Sciences) was registered on 2024-05-22, making it 781 days old as of the analysis date.
Domain & digital trail
Domain registered
2024-05-22 (2.1 age)
Registrar
GoDaddy.com, LLC
TLS
Google Trust Services

Sources

Show all 79 sources

For lab operators

Run this lab? You can confirm the entry and correct it.

Claim this lab
This profile is built from public sources and reviewed by hand. It shows where each fact comes from. A listing is a set of signals, not an endorsement or a verdict - and never a guarantee. Presence and order cannot be purchased.